Acta Med. 2009, 52: 149-153
https://doi.org/10.14712/18059694.2016.121
RANK/RANKL Expression Is Induced by Cardiac Surgical Operation
References
1. AP, Schwarz EM. Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications. J Cell Biochem 2006; 97:226–32.
<https://doi.org/10.1002/jcb.20674>
2. A, Abbate A, Girola F, et al. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardio- Thor Surgery 2004; 25:304–11.
<https://doi.org/10.1016/j.ejcts.2003.12.003>
3. GJ, Kostakis P, Vincent C, et al. RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 2006; 21:1339–49.
<https://doi.org/10.1359/jbmr.060604>
4. A, Lante W, Fackeldey V, et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardio-Thor Surgery 2005; 28:569–75.
<https://doi.org/10.1016/j.ejcts.2005.07.007>
5. UK, Malik V, Yadav R, et al. Myocardial injury in coronary artery bypass grafting: On-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release. J Thorac Cardiovasc Surg 2008; 135:1110–9.
<https://doi.org/10.1016/j.jtcvs.2007.12.029>
6. A, Micari A, Altavilla D, et al. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction. Clin Science 2005; 109:389–95.
<https://doi.org/10.1042/CS20050058>
7. K, Trojáčková Kudlová M, Koláčková M, et al. The effect of cardiac surgery on peripheral blood lymphocyte populations. Acta Med 2008; 51:25–9.
8. M, Kudlová M, Kuneš P, et al. Early expression of FcγRI (CD64) on monocytes of cardiac surgical patients and higher density of monocyte anti-inflammatory scavenger CD163 receptor in „on-pump“ patients. Med Inflamm 2008; 235461.
9. M, Trojáčková Kudlová M, Lonský V, et al. The expression of CD38 ADP-ribosyl cyclase ectoenzyme in immune cells of cardiac surgical patients. Acta Med 2008; 51:31–5.
10. J, Kuneš P, Koláčková M, et al. The expression of Toll-like receptor 2 and 4 on innate immunity cells is modulated by cardiac surgical operation. Scand J Clin Lab Invest 2008; 68:749–58.
<https://doi.org/10.1080/00365510802233434>
11. M, Koláčkova M, Kuneš P, et al. Expression of an activated form of integrin β2 chain CD18 in cardiac surgical operations. Acta Med 2007; 50:187–93.
12. J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocrine Reviews 2008; 29:403–40.
<https://doi.org/10.1210/er.2007-0038>
<PubMed>
13. UM, Kim N, Choi Y, Farrell JP. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice. J Immunol 2003; 171: 5437–41.
<https://doi.org/10.4049/jimmunol.171.10.5437>
14. D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardio-Thor Surgery 2002; 21:232–44.
<https://doi.org/10.1016/S1010-7940(01)01099-5>
15. PE, Chakravarti A, Fernandes MJ, Doiron K, Marceau AA. Differential expression of RANK, RANKL, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils. Arthritis Research Therapy 2007; 9:R25.
<https://doi.org/10.1186/ar2137>
<PubMed>
16. AJ, Bittner HB, Gummert JF, et al. On-pump beating heart versus offpump coronary artery bypass surgery-evidence of pump-induced myocardial injury. Eur J Cardio-Thor Surgery 2005; 27:1057–64.
<https://doi.org/10.1016/j.ejcts.2005.03.007>
17. M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol 2007; 143:31–48.
<https://doi.org/10.1159/000098223>
18. WJ, Yndestad A, Oie E, et al. Enhanced T-cell expression of RANK ligand in acute coronary syndrome. Arterioscler Thromb Vasc Biol 2006; 26: 857–63.
<https://doi.org/10.1161/01.ATV.0000204334.48195.6a>
19. T, Gullestad L, Simonsen S, et al. Decreased endomyocardial RANKL expression in transplant coronary artery disease. Transplantation 2006; 81: 1467–1470.
<https://doi.org/10.1097/01.tp.0000209413.45179.f6>
20. T, Yndestad A, Oie E, et al. Dysregulated osteoprotegerin/RANK ligand/ RANK axis in clinical and experimental heart failure. Circulation 2005; 111:2461–8.
<https://doi.org/10.1161/01.CIR.0000165119.62099.14>


